Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Andriani

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre studyA Andriani, A Zullo, F Di Raimondo, et al.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre studyA Andriani, A Zullo, F Di Raimondo, et al.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Pageof 4